| Title | Experimental Oncology |
| Abbreviation | Exp. Oncol. |
| Publication Type | Journal |
| Subject Area, Categories, Scope | Cancer Research (Q4); Oncology (Q4) |
| h-index | 48 |
| Overall Rank/Ranking | 17531 |
| SCImago Journal Rank (SJR) | 0.25 |
| Impact Score | 0.62 |
| Publisher | Morion LLC |
| Country | Ukraine |
| ISSN | 18129269 |
| Best Quartile | Q4 |
| Coverage History | 1984-2023 |
Experimental Oncology is a journal covering the technologies/fields/categories related to Cancer Research (Q4); Oncology (Q4). It is published by Morion LLC. The overall rank of Experimental Oncology is 17531. According to SCImago Journal Rank (SJR), this journal is ranked 0.25. SCImago Journal Rank is an indicator, which measures the scientific influence of journals. It considers the number of citations received by a journal and the importance of the journals from where these citations come. SJR acts as an alternative to the Journal Impact Factor (or an average number of citations received in last 2 years). This journal has an h-index of 48. The best quartile for this journal is Q4.
The ISSN of Experimental Oncology journal is 18129269. An International Standard Serial Number (ISSN) is a unique code of 8 digits. It is used for the recognition of journals, newspapers, periodicals, and magazines in all kind of forms, be it print-media or electronic. Experimental Oncology is cited by a total of 149 articles during the last 3 years (Preceding 2023).
The Impact IF 2023 of Experimental Oncology is 0.62, which is computed in 2024 as per its definition. Experimental Oncology IF is decreased by a factor of 0.22 and approximate percentage change is -26.19% when compared to preceding year 2022, which shows a falling trend. The impact IF, also denoted as Journal impact score (JIS), of an academic journal is a measure of the yearly average number of citations to recent articles published in that journal. It is based on Scopus data.
Impact IF 2023 of Experimental Oncology is 0.62. If the same downward trend persists, Impact IF may fall in 2024 as well.
| Year | Impact IF |
|---|---|
| 2023/2024 | Coming Soon |
| 2023 | 0.62 |
| 2022 | 0.84 |
| 2021 | 1.03 |
| 2020 | 0.98 |
| 2019 | 0.83 |
| 2018 | 0.84 |
| 2017 | 0.85 |
| 2016 | 1.05 |
| 2015 | 1.18 |
| 2014 | 2.38 |
Experimental Oncology has an h-index of 48. It means 48 articles of this journal have more than 48 number of citations. The h-index is a way of measuring the productivity and citation impact of the publications. The h-index is defined as the maximum value of h such that the given journal/author has published h papers that have each been cited at least h number of times.
The ISSN of Experimental Oncology is 18129269. ISSN stands for International Standard Serial Number.
An ISSN is a unique code of 8 digits. It is used for the recognition of journals, newspapers, periodicals, and magazines in all kind of forms, be it print-media or electronic.
The overall rank of Experimental Oncology is 17531. According to SCImago Journal Rank (SJR), this journal is ranked 0.25. SCImago Journal Rank is an indicator, which measures the scientific influence of journals. It considers the number of citations received by a journal and the importance of the journals from where these citations come.
| Year | SJR |
|---|---|
| 2023/2024 | Coming Soon |
| 2023 | 0.25 |
| 2022 | 0.250 |
| 2021 | 0.272 |
| 2020 | 0.281 |
| 2019 | 0.276 |
| 2018 | 0.366 |
| 2017 | 0.444 |
| 2016 | 0.388 |
| 2015 | 0.943 |
| 2014 | 0.753 |
| Year | Ranking |
|---|---|
| 2023/2024 | Coming Soon |
| 2023 | 17531 |
| 2022 | 16874 |
| 2021 | 15691 |
| 2020 | 15474 |
| 2019 | 15190 |
| 2018 | 12045 |
| 2017 | 10115 |
| 2016 | 11286 |
| 2015 | 4813 |
| 2014 | 6136 |
Experimental Oncology is published by Morion LLC. It's publishing house is located in Ukraine. Coverage history of this journal is as following: 1984-2023. The organization or individual who handles the printing and distribution of printed or digital publications is known as Publisher.
Visit the official website of the journal/conference to check the further details about the call for papers.
The IS0 4 standard abbreviation of Experimental Oncology is Exp. Oncol.. This abbreviation ('Exp. Oncol.') is well recommended and approved for the purpose of indexing, abstraction, referencing and citing goals. It meets all the essential criteria of ISO 4 standard.
ISO 4 (International Organization for Standardization 4) is an international standard that defines a uniform and consistent system for abbreviating serial publication titles and journals.
If your research field is/are related to Cancer Research (Q4); Oncology (Q4), then please visit the official website of this journal.
The acceptance rate/percentage of any academic journal/conference depends upon many parameters. Some of the critical parameters are listed below.
It is essential to understand that the acceptance rate/rejection rate of papers varies among journals. Some Journals considers all the manuscripts submissions as a basis of acceptance rate computation. On the other hand, few consider the only manuscripts sent for peer review or few even not bother about the accurate maintenance of total submissions. Hence, it can provide a rough estimation only.
The best way to find out the acceptance rate is to reach out to the associated editor or to check the official website of the Journal/Conference.
Experimental Oncology latest impact IF is 0.62. It's evaluated in the year 2023. The highest and the lowest impact IF or impact score of this journal are 2.38 (2014) and 0.62 (2023), respectively, in the last 10 years. Moreover, its average IS is 1.06 in the previous 10 years.
The Experimental Oncology has an SJR (SCImago Journal Rank) of 0.25, according to the latest data. It is computed in the year 2024. In the past 10 years, this journal has recorded a range of SJR, with the highest being 0.943 in 2015 and the lowest being 0.25 in 2023. Furthermore, the average SJR of the Experimental Oncology over the previous 10-year period stands at 1.06.
The latest h-index of the Experimental Oncology is 48.
The Experimental Oncology is published by the Morion LLC, with its country of publication being the Ukraine.
The Experimental Oncology is currently ranked 17531 out of 27955 Journals, Conferences, and Book Series in the latest ranking. Over the course of the last 10 years, this journal has experienced varying rankings, reaching its highest position of 4813 in 2015 and its lowest position of 17531 in 2023.
The standard ISO4 abbreviation for the Experimental Oncology is Exp. Oncol..
Experimental Oncology is classified as a journal that the Morion LLC publishes.
The Experimental Oncology encompasses the following areas:
For a more comprehensive understanding of its scope, check the official website of this journal.
The Experimental Oncology is assigned the following International Standard Serial Numbers (ISSN): 18129269.
The best quartile for the Experimental Oncology is Q4 (2023).
The Experimental Oncology coverage history can be summarized as follows: 1984-2023.
| Journal/Conference/Workshop/Book Title | Type | Ranking | Publisher | h-index | Impact Score |
|---|---|---|---|---|---|
| Journal of Business Economics and Management | journal | 9513 | Vilnius Gediminas Technical University | 48 | 3.30 |
| International Journal of Mathematical Education in Science and Technology | journal | 8417 | Taylor and Francis Ltd. | 42 | 1.17 |
| Mathematical Modelling and Analysis | journal | 11193 | Vilnius Gediminas Technical University | 29 | 1.75 |
| International Journal of Applied Linguistics | journal | 6241 | Wiley-Blackwell Publishing Ltd | 53 | 1.91 |
| International Conference on Architectural Support for Programming Languages and Operating Systems - ASPLOS | conference and proceedings | 678 | Association for Computing Machinery (ACM) | 106 | 7.58 |
| Biological Procedures Online | journal | 4092 | BioMed Central Ltd | 48 | 3.54 |
| Museum Management and Curatorship | journal | 10406 | Routledge | 40 | 1.72 |
| Asian Textile Journal | trade journal | 27997 | G P S Kwatra | 11 | 0.03 |
| Journal of Sociology | journal | 5238 | SAGE Publications Ltd | 62 | 2.22 |
| European Journal of Cancer, Supplement | journal | 6710 | Elsevier Ltd | 29 | 0.33 |
| Year | Impact Score (IS) |
|---|---|
| 2024/2025 | Coming Soon |
| 2023 | 0.62 |
| 2022 | 0.84 |
| 2021 | 1.03 |
| 2020 | 0.98 |
| 2019 | 0.83 |
| 2018 | 0.84 |
| 2017 | 0.85 |
| 2016 | 1.05 |
| 2015 | 1.18 |
| 2014 | 2.38 |
